In a groundbreaking study published on March 5, 2026, researchers have unveiled an unprecedented link between the gut microbiota and renal cell carcinoma (RCC), one of the most prevalent and lethal forms of kidney cancer. This novel research, led by Lee et al., demonstrates that the probiotic strain Lacticaseibacillus rhamnosus Fb7-311 can modulate the epigenetic regulator EHMT2
Gut Microbiota Modulates EHMT2 to Fight Kidney Cancer
ADVERTISEMENT
Related Posts
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!